tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH
Advertisement

Theravance Biopharma (TBPH) Revenue

Compare
318 Followers

Theravance Biopharma Revenue

Theravance Biopharma had a revenue of 26.20M in the quarter ending Jun 30, 2025, with 70.23%. This bring the company's revenue in the last twelve months to 77.20M, Decreased 18.29%. In the fiscal year ending Dec 31, 2024, Theravance Biopharma had annual revenue of 64.38M with 12.12% growth.
Revenue (ttm)
77.20M
Revenue Growth
24.49%
P/S Ratio
10.72
Revenue/Employee
$663,722
Employees
97
Market Cap
$689.95M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
64.38M6.96M+12.12%
Dec 31, 2023
57.42M6.08M+11.84%
Dec 31, 2022
51.35M-3.96M-7.17%
Dec 31, 2021
55.31M-16.55M-23.03%
Dec 31, 2020
71.86M-1.56M-2.12%
Dec 31, 2019
73.41M13.04M+21.61%
Dec 31, 2018
60.37M44.98M+292.37%
Dec 31, 2017
15.39M-33.26M-68.37%
Dec 31, 2016
48.65M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis